Simulations Plus, Inc. (SLP:NASDAQ) closed at $18.50 on October 5, 2026, unchanged on the day. The stock trades 11.9% below its 52-week high of $21.01 and 66.8% above its 52-week low of $11.09. Simulations Plus, Inc. is part of the Technology sector (EDP Services).
In 252 trading sessions since October 22, 2025, SLP closed higher on 125 days (50%). Its best day was December 2, 2025 (+14.14%) and its worst was May 11, 2026 (-11.93%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 3 times.
Simulations Plus, Inc. develops and sells drug discovery and development software for mechanistic modeling and simulation. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; and KIWI, a cloud-based Web application, which organizes, processes, maintains, and communicates the volume of data and res...
Find more stocks like SLP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.